EFFECT OF INSULIN TREATMENT INTENSIFICATION WITH INSULIN GLULISINE ADDED TO INSULIN GLARGINE IN TYPE 2 DIABETES PATIENTS IN ROMANIA

被引：0

作者：

Guja, Cristian ^{[1
,2
]}

Ioacara, Sorin ^{[2
,3
]}

Catrinoiu, Doina ^{[4
]}

Negrisanu, Gabriela ^{[5
]}

Popa, Amorin ^{[6
]}

机构：

[1] Prof NC Paulescu Natl Inst Diabet Nutr & Metab Di, Bucharest, Romania

[2] Carol Davila Univ Med & Pharm, Bucharest, Romania

[3] Elias Emergencya Univ Hosp, Dept Diabet & Metab & Dis, Bucharest, Romania

[4] Emergency Clin Cty Hosp, Diabet Clin, Constanta, Romania

[5] Victor Babes Univ Med & Pharm, Timisoara, Romania

[6] Emergency Clin Cty Hosp, Diabet & Internal Med Clin, Oradea, Romania

来源：

INTERDISCIPLINARY APPROACHES IN DIABETIC CHRONIC KIDNEY DISEASE | 2015年

关键词：

diabetes; insulin treatment; insulin glargine; insulin glulisine real-life clinical practice; EUROPEAN ASSOCIATION; BASAL-BOLUS; THERAPY; HYPERGLYCEMIA; MANAGEMENT; STATEMENT;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We aimed to assess in real life setting the effect on glycemic control in T2DM patients of insulin treatment intensification according to the 2008 ADA/EASD algorithm, using insulin glulisine on top of insulin glargine. We analyzed 1707 adult T2DM patients treated with glargine and glulisine for 6 +/- 1 months. Insulin glulisine was added if HbA1c > 7%. Comparison between quantitative variables was made with the Student t test or Fisher exact text using the SPSS v21 software. HbA1c decreased significantly with 1.55% (p<0.001) while mean FBG decreased to 119.2 mg%. Overall 42.6% of patients reached the HbA1c target < 7%. Mean number of documented hypoglycemic episodes (glycaemia < 72 mg/dl) was 0.79/patient. In 1235 patients (72.3%) no hypoglycemic episodes have been registered. In conclusion our data suggest the efficacy and safety of treatment intensification with insulin glulisine in T2DM patients not controlled with glargine basal insulin combined with oral drugs.

引用

页码：230 / 239

页数：10

共 17 条

[1] Glycemic Targets
不详
[J]. DIABETES CARE, 2015, 38 : S33 - S40
[2] [Anonymous], ACTA DIABETOLOGICA R
[3] [Anonymous], 2014, IDF Diabetes Atlas, V6th
[4] Optimization of insulin therapy in patients with Type 2 diabetes mellitus: beyond basal insulin
Blak, B. T.
Smith, H. T.
Hards, M.
Curtis, B. H.
Ivanyi, T.
[J]. DIABETIC MEDICINE, 2012, 29 (07) : E13 - E20
[5] Comparison between a basal-bolus and a premixed insulin regimen in individuals with type 2 diabetes-results of the GINGER study
Fritsche, A.
Larbig, M.
Owens, D.
Haering, H.-U.
[J]. DIABETES OBESITY & METABOLISM, 2010, 12 (02) : 115 - 123
[6] Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524
[7] Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
Inzucchi, Silvio E.
Bergenstal, Richard M.
Buse, John B.
Diamant, Michaela
Ferrannini, Ele
Nauck, Michael
Peters, Anne L.
Tsapas, Apostolos
Wender, Richard
Matthews, David R.
[J]. DIABETES CARE, 2015, 38 (01) : 140 - 149
[8] Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Inzucchi, Silvio E.
Bergenstal, Richard M.
Buse, John B.
Diamant, Michaela
Ferrannini, Ele
Nauck, Michael
Peters, Anne L.
Tsapas, Apostolos
Wender, Richard
Matthews, David R.
[J]. DIABETES CARE, 2012, 35 (06) : 1364 - 1379
[9] Study of Once Daily Levemir (SOLVE™): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice
Khunti, K.
Damci, T.
Meneghini, L.
Pan, C. Y.
Yale, J. -F.
[J]. DIABETES OBESITY & METABOLISM, 2012, 14 (07) : 654 - 661
[10] Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs
Lankisch, M. R.
Ferlinz, K. C.
Leahy, J. L.
Scherbaum, W. A.
[J]. DIABETES OBESITY & METABOLISM, 2008, 10 (12) : 1178 - 1185

← 1 2 →